Kewaunee Scientific Corp Files 8-K on Shareholder Votes

TL;DR

Kewaunee Scientific Corp held a shareholder vote on Aug 27th. Details to follow.

AI Summary

Kewaunee Scientific Corporation filed an 8-K on August 29, 2025, reporting on matters submitted to a vote of security holders as of August 27, 2025. The filing details the company's corporate information, including its incorporation in Delaware and principal executive offices in Statesville, North Carolina.

Why It Matters

This filing indicates that Kewaunee Scientific Corporation held a vote of its security holders, which could pertain to significant corporate decisions or governance matters.

Risk Assessment

Risk Level: low — The filing is a routine 8-K reporting a vote of security holders, with no immediate indication of significant financial distress or major operational changes.

Key Numbers

• 20250827 — Date of earliest event reported (This is the date the reported event, a vote of security holders, occurred.)
• 20250829 — Filing Date (This is the date the 8-K report was officially filed with the SEC.)

Key Players & Entities

• Kewaunee Scientific Corporation (company) — Registrant
• Delaware (jurisdiction) — State of incorporation
• Statesville, North Carolina (location) — Location of principal executive offices

FAQ

Key Financial Figures

• $2.50 — nge on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Ma

Filing Documents

• d25139d8k.htm (8-K) — 34KB
• 0001193125-25-192132.txt ( ) — 142KB
• kequ-20250827.xsd (EX-101.SCH) — 3KB
• kequ-20250827_lab.xml (EX-101.LAB) — 17KB
• kequ-20250827_pre.xml (EX-101.PRE) — 11KB
• d25139d8k_htm.xml (XML) — 3KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 27, 2025 Kewaunee Scientific Corporation (Exact name of registrant as specified in its charter) Delaware 0-5286 38-0715562 (State or other jurisdiction (Commission (IRS. Employer of incorporation) File Number) Identification No.) 2700 West Front Street 28677 (Address of principal executive offices) (Zip Code) Registrant's telephone number, including area code: 704 - 873-7202 N/A (Former name or former address, if changed since last report.) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $2.50 par value KEQU The Nasdaq Global Market Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.07 Submission of Matters to a Vote of Security Holders. On August 27, 2025, Kewaunee Scientific Corporation (the "Company") held its Annual Meeting of Shareholders (the "Annual Meeting"). At the Annual Meeting, the Company's shareholders voted on the matters set forth below. 1.The nominees named below were re-elected as Class III directors for three-year terms as follows: Name of Nominee For Withheld Non-Votes Margaret B. Pyle 1,633,067 189,229 537,449 Donald F. Shaw 1,730,171 92,125 537,449 2.The appointment of the independent registered public accounting firm of Forvis Mazars, LLP as the Company's independent auditors for fiscal year 2026 was ratified as follows: For Against Abstained 2,356,636 2,119 990 3.The compensation of the Company's named executive officers was approved on an advisory basis as follows: For Against Abstained Non-Votes 1,448,991 103,177 270,128 537,449 4.An advisory vote on whether the frequency of holding an advisory vote on the compensation of our named executive officers should be every one year, two years, or three years resulted in the following votes: 1 Year 2 Years 3 Years Abstained Non-Votes 1,512,884 1,194 306,985 1,233 537,449 In accordance with the recommendation of the Company's Board of Directors and consistent with the vote of the Company's stockholders, the Company will include an advisory non-binding vote of the Company's stockholders on the compensation of the Company's named executive officers in its proxy materials on an annual basis until the occurrence of the next advisory vote on the frequency of future advisory votes on the compensation of our named executive officers or until the Board of Directors determines that a different frequency is in the best interests of the Company's stockholders. Signature Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. (Registrant) Kewaunee Scientific Corporation Date: August 29, 2025 /s/ Donald T. Gardner III Donald T. Gardner III Vice President, Finance and Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR